CD46 Gene Hemolytic Uremic Syndrome Atypical Type 2 Susceptibility To Genetic Test sale cost 4400 AED
F13A1 Gene Factor XIIIA Deficiency Genetic Test sale cost 4400 AED F13A1 Gene Factor XIIIA Deficiency Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
UGT1A1 Gene Hyperbilirubinemia Familial Transient Neonatal Genetic Test sale cost 4400 AED UGT1A1 Gene Hyperbilirubinemia Familial Transient Neonatal Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CD46 Gene Hemolytic Uremic Syndrome Atypical Type 2 Susceptibility To Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CD46 Gene Hemolytic Uremic Syndrome (aHUS) Atypical Type 2 Susceptibility genetic test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the CD46 gene. These mutations are associated with an increased risk of developing Atypical Hemolytic Uremic Syndrome Type 2, a rare, life-threatening genetic disorder. aHUS leads to the abnormal destruction of red blood cells, reduced blood flow to organs, and kidney failure due to the formation of blood clots in small blood vessels. The CD46 gene plays a crucial role in regulating the immune system’s complement pathway, which, when dysregulated, contributes to the development of aHUS.

The test is priced at 4400 AED and is designed for individuals who may be at risk of this condition, either due to a family history or presenting symptoms suggestive of aHUS. Early detection through this genetic test can be crucial for the timely management and treatment of the condition, potentially preventing its progression and associated complications. DNA Labs UAE provides this testing service with a focus on accuracy, confidentiality, and support for patients and their families navigating the implications of genetic risk factors for aHUS.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CD46 Gene Hemolytic Uremic Syndrome Atypical Type 2 Susceptibility to Genetic Test

Test Name: CD46 Gene Hemolytic Uremic Syndrome Atypical Type 2 Susceptibility to Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Hepatology Nephrology Endocrinology Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for CD46 Gene Hemolytic Uremic Syndrome, Atypical Type 2, Susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD46 Gene Hemolytic Uremic Syndrome, Atypical Type 2, Susceptibility to NGS Genetic DNA Test gene CD46.

Test Details:

CD46 gene hemolytic uremic syndrome, atypical type 2 is a genetic disorder characterized by abnormal activation of the complement system, leading to the destruction of red blood cells, low platelet count, and kidney damage. It is an atypical form of hemolytic uremic syndrome (HUS) that is caused by mutations in the CD46 gene. The CD46 gene provides instructions for producing a protein called membrane cofactor protein (MCP). MCP helps regulate the complement system, which is part of the immune system that helps destroy foreign invaders. Mutations in the CD46 gene can disrupt the function of MCP, leading to uncontrolled activation of the complement system.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. It uses advanced sequencing technologies to rapidly sequence the DNA and identify mutations or variations in specific genes, including the CD46 gene. NGS testing can help identify the specific genetic changes responsible for hemolytic uremic syndrome and provide information about the individual’s susceptibility to the disorder.

By identifying the genetic mutations associated with CD46 gene hemolytic uremic syndrome, atypical type 2, NGS testing can help with diagnosis, prognosis, and treatment decisions. It can also be used for genetic counseling and family planning purposes, as it can determine the likelihood of passing on the condition to future generations.

Test Name CD46 Gene Hemolytic uremic syndrome atypical type 2 susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CD46 Gene Hemolytic uremic syndrome, atypical type 2, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD46 Gene Hemolytic uremic syndrome, atypical type 2, susceptibility to NGS Genetic DNA Test gene CD46
Test Details

CD46 gene hemolytic uremic syndrome, atypical type 2 is a genetic disorder characterized by abnormal activation of the complement system, leading to the destruction of red blood cells, low platelet count, and kidney damage. It is an atypical form of hemolytic uremic syndrome (HUS) that is caused by mutations in the CD46 gene.

The CD46 gene provides instructions for producing a protein called membrane cofactor protein (MCP). MCP helps regulate the complement system, which is part of the immune system that helps destroy foreign invaders. Mutations in the CD46 gene can disrupt the function of MCP, leading to uncontrolled activation of the complement system.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. It uses advanced sequencing technologies to rapidly sequence the DNA and identify mutations or variations in specific genes, including the CD46 gene. NGS testing can help identify the specific genetic changes responsible for hemolytic uremic syndrome and provide information about the individual’s susceptibility to the disorder.

By identifying the genetic mutations associated with CD46 gene hemolytic uremic syndrome, atypical type 2, NGS testing can help with diagnosis, prognosis, and treatment decisions. It can also be used for genetic counseling and family planning purposes, as it can determine the likelihood of passing on the condition to future generations.

SKU: TEST-3647 Category:

Related products